UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: March 27, 2023
Accession Number: 0001493152-23-008859
Submission Type: POS AM
CIK: 0001517681
Company Name: Propanc Biopharma, Inc.
File Number: 333-238240